NIH Highlighted Topic: BRAIN Initiative: Data Knowledgebase Ecosystem and NeuroAI Integration
Below is a brief summary. Please check the full solicitation before applying (link in resources section).
Executive Summary:
The National Institutes of Health (NIH) is encouraging innovative research proposals focused on advancing the BRAIN Initiative through the development of interconnected neuroscience data ecosystems, AI-enabled knowledgebases, and transformative NeuroAI technologies. This highlighted topic supports multidisciplinary efforts integrating neuroscience, artificial intelligence, computational modeling, neuromorphic computing, brain mapping, and large-scale data infrastructure to accelerate understanding of the human brain and improve human health outcomes.
NIH is particularly interested in projects that create federated neuroscience data commons, standardized brain mapping frameworks, neural connectivity atlases, cross-species ontologies, synchronized neural-behavioral datasets, and AI-powered discovery platforms. Companies developing NeuroAI systems, brain data infrastructure, neuromorphic computing technologies, computational neuroscience platforms, knowledge graphs, neural analytics tools, or advanced neuroscience software may be strong candidates for funding.
Areas of interest include interpretable AI models for neuroscience, energy-efficient neuromorphic platforms, brain-body systems modeling, real-time neural processing systems, predictive neuroscience analytics, cross-modal data integration, knowledge graph development, open-source neuroscience infrastructure, and computational tools that improve reproducibility and transparency in neuroscience research. NIH is also encouraging technologies that support bidirectional learning between biological neuroscience and brain-inspired computing architectures.
Funding is available through the NIH SBIR/STTR Program, which currently provides up to approximately $323,090 for Phase I projects and up to $2,153,927 for Phase II projects, with opportunities for additional commercialization and follow-on funding depending on project scope and translational impact.
This highlighted topic is supported by multiple NIH Institutes and Centers participating in the NIH BRAIN Initiative, including NINDS, NIMH, NIBIB, NIA, NIDA, NIDCD, NCCIH, NEI, and ORWH, all of which are seeking transformative innovations that advance NeuroAI, computational neuroscience, brain mapping, and next-generation neurotechnology development.
How much funding would I receive?
Awards provide up to $323,090 for Phase I projects (up to 2 years) and $2,153,927 for Phase II projects (up to 3 years). Some topics approved by NIH may exceed these limits. Fast-Track and Phase IIB (follow-on) options allow continuous or extended funding beyond Phase II.
What could I use the funding for?
Funding may support the research, development, validation, and commercialization of NeuroAI platforms, neuroscience data ecosystems, computational tools, brain mapping technologies, and neuromorphic computing systems.
Eligible activities may include:
AI and machine learning platforms for neuroscience research
Federated neuroscience data commons and knowledgebase infrastructure
Brain mapping and neural connectivity atlas technologies
Cross-species neuroscience ontology and data integration systems
Knowledge graph development for neuroscience applications
Computational neuroscience and predictive brain modeling platforms
Neuromorphic computing and brain-inspired hardware systems
Real-time neural processing and adaptive monitoring technologies
Brain-behavior data synchronization and analytics platforms
Open-source neuroscience software and analytical tools
Cross-modal neuroscience data integration systems
Interpretable AI models for mechanistic neuroscience discovery
Brain-body systems modeling and embodied intelligence research
Neurotechnology platforms supporting health monitoring applications
High-performance computing infrastructure for neuroscience data analysis
Reproducibility and transparency tools for neuroscience research
Prototype development, translational research, and validation studies
Commercialization planning, regulatory preparation, and scale-up activities
Funding may also support personnel, software engineering, cloud computing infrastructure, AI model development, data architecture, computational biology research, neuroscience validation studies, bioinformatics pipelines, intellectual property protection, regulatory strategy, and commercialization activities necessary to advance a scalable and commercially viable NeuroAI or neuroscience technology solution aligned with NIH priorities.
Are there any additional benefits I would receive?
Beyond the formal funding award, awardees gain several strategic advantages:
Government Validation and Credibility:
Being selected for an NIH-backed SBIR grant signals technical excellence and alignment with national health and biomedical priorities. This validation builds investor and partner confidence.Enhanced Visibility and Market Recognition:
Awardees are featured in NIH and HHS announcements, helping attract partnerships, media attention, and future contracting opportunities.Access to the Federal Innovation Ecosystem:
Recipients join a national network of researchers and agencies advancing life science innovation, often opening doors to collaborations with NIH laboratories and federal health programs.Stronger Commercial and Exit Potential:
By maturing technology through nondilutive funding, companies strengthen valuation, de-risk commercialization, and increase attractiveness for acquisition or follow-on private investment.
What is the timeline to apply and when would I receive funding?
Applications are accepted each year on January 5th, April 5th, and September 5th. Funding is received approximately 9 months after submission.
Where does this funding come from?
Funding comes from the U.S. Department of Health and Human Services, with statutory set-asides requiring NIH, CDC, and FDA to devote portions of their extramural R&D budgets (3.2% for SBIR, 0.45% for STTR) to support small business innovation.
Who is eligible to apply?
Applicants must be U.S. small business concerns (SBCs) that:
Are organized for profit with a U.S. place of business.
Have ≤ 500 employees including affiliates.
Are > 50% owned by U.S. citizens or permanent residents, qualifying U.S. entities, or combinations thereof.
What companies and projects are likely to win?
Projects that demonstrate:
A clear unmet medical or public-health need,
Strong scientific rationale and feasibility,
High commercialization potential, supported by a realistic market and regulatory strategy, and
Alignment with an NIH Institute’s or CDC/FDA Center’s specific research mission (e.g., infectious disease, digital health, diagnostics, therapeutics, or data analytics).
Competitive applicants often have an early prototype, preliminary data, and a defined path to market adoption.
Are there any restrictions I should know about?
Companies must complete multiple federal registrations (SAM.gov, Grants.gov, eRA Commons, SBA Company Registry) before applying.
Foreign entities are not eligible.
Disclosure of foreign affiliations and compliance with national security screening are mandatory. Currently we do not recommend any sort of foreign affiliation.
How long will it take me to prepare an application?
For a first-time applicant, preparing a competitive submission will likely take 120–200 hours in total.
How can BW&CO help?
Our team specializes in complex federal R&D proposals and can:
Triple your likelihood of success through proven strategy and insider-aligned proposal development
Reduce your time spent on the proposal by 50–80%, letting your team focus on technology and operations
Ensure you are targeting the best opportunity for your project and positioning your company for long-term growth.
